Extensively Drug-Resistant Tuberculosis (XDR-TB) Therapeutics Market Size, Share, and Global Outlook: 2026 to 2033
Extensively Drug-Resistant Tuberculosis (XDR-TB) presents a critical global health challenge, caused by Mycobacterium tuberculosis strains that are resistant to first-line drugs, fluoroquinolones, and at least one additional second-line injectable drug or novel agent like bedaquiline. Market Overview & Growth Drivers The global Xdr-Tb Treatment Market is expanding...
0 Reacties 0 aandelen 23 Views 0 voorbeeld